112 results
S-3ASR
EX-1.2
ZNTL
Zentalis Pharmaceuticals Inc
29 Feb 24
Automatic shelf registration
5:14pm
sanctions administered or enforced by the U.S. Department of the Treasury’s Office of Foreign Assets Control, the United Nations Security Council … fees and associated expenses of the Agent’s outside legal counsel for filings with the FINRA Corporate Financing Department in an amount
8-K
EX-99.1
q84m567gx0
9 Aug 23
Zentalis Pharmaceuticals Reports Second Quarter 2023 Financial Results and Operational Updates
7:03am
8-K
EX-1.1
9asmbebkwwm4qh
15 Jun 23
Other Events
4:23pm
424B5
onp8 07bsn1p7jc4lplf
15 Jun 23
Prospectus supplement for primary offering
4:12pm
FWP
pez2ifejf9v7
15 Jun 23
Free writing prospectus
7:03am
8-K
EX-99.1
ryoew
6 Jun 23
Zentalis Announces Intermittent Azenosertib Monotherapy Dosing Nearly Doubles Efficacy Over Continuous Dosing
9:10am
8-K
EX-99.3
oitks
6 Jun 23
Zentalis Announces Intermittent Azenosertib Monotherapy Dosing Nearly Doubles Efficacy Over Continuous Dosing
9:10am
8-K
EX-99.1
riniky
5 Jun 23
Regulation FD Disclosure
2:24pm